5.56 - 5.56
4.95 - 8.28
45 / 2.4K (Avg.)
-278.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
6.35%
Positive revenue growth while VALMT.HE is negative. John Neff might see a notable competitive edge here.
16.80%
Positive gross profit growth while VALMT.HE is negative. John Neff would see a clear operational edge over the competitor.
19.63%
Positive EBIT growth while VALMT.HE is negative. John Neff might see a substantial edge in operational management.
19.63%
Positive operating income growth while VALMT.HE is negative. John Neff might view this as a competitive edge in operations.
18.73%
Positive net income growth while VALMT.HE is negative. John Neff might see a big relative performance advantage.
21.43%
Positive EPS growth while VALMT.HE is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
21.43%
Positive diluted EPS growth while VALMT.HE is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-2.23%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-2.23%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
19.74%
Positive OCF growth while VALMT.HE is negative. John Neff would see this as a clear operational advantage vs. the competitor.
970.59%
Positive FCF growth while VALMT.HE is negative. John Neff would see a strong competitive edge in net cash generation.
-26.09%
Negative 10Y revenue/share CAGR while VALMT.HE stands at 8.94%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
1.14%
5Y revenue/share CAGR under 50% of VALMT.HE's 32.45%. Michael Burry would suspect a significant competitive gap or product weakness.
8.90%
3Y revenue/share CAGR above 1.5x VALMT.HE's 5.43%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
591.58%
10Y OCF/share CAGR at 75-90% of VALMT.HE's 701.23%. Bill Ackman would demand strategic changes to close the gap in long-term cash generation.
299.37%
Positive OCF/share growth while VALMT.HE is negative. John Neff might see a comparative advantage in operational cash viability.
258.96%
3Y OCF/share CAGR under 50% of VALMT.HE's 902.04%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
148.99%
Similar net income/share CAGR to VALMT.HE's 158.86%. Walter Schloss would see parallel tailwinds or expansions for both firms.
150.10%
Below 50% of VALMT.HE's 617.72%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
142.86%
3Y net income/share CAGR 75-90% of VALMT.HE's 158.86%. Bill Ackman might push for an operational plan to match or beat the competitor’s short-term growth.
No Data
No Data available this quarter, please select a different quarter.
53.48%
5Y equity/share CAGR above 1.5x VALMT.HE's 13.64%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
25.43%
3Y equity/share CAGR above 1.5x VALMT.HE's 8.15%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
14.29%
Our AR growth while VALMT.HE is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
10.73%
Inventory growth well above VALMT.HE's 11.69%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-0.40%
Negative asset growth while VALMT.HE invests at 5.05%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-1.83%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-11.02%
We’re deleveraging while VALMT.HE stands at 78.61%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-100.00%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-2.89%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.